Ignite SD
0
Login
Register
Viewing StudyNCT03443830
Home
Search
Stocks
Certify Doc
Genes
Clinical Trials
CompTox
DrugMatrix
Open Targets
Products
Support
Bugs
eRecord
Main Search
All Studies
All Organizations
Report Bug
View Study With Definitions
Ignite Creation Date:
2024-05-06 @ 11:10 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03443830
Status:
COMPLETED
Last Update Posted:
2019-04-10
First Post:
2018-02-08
Brief Title:
Safety and Tolerability of an Antibody Against Zika Virus Tyzivumab in Humans
Sponsor:
Tychan Pte Ltd
Organization:
Tychan Pte Ltd
Overview
Dates
Organization
Conditions
Design
Enrollment
Locations
Outcomes
Organization Data
Organization:
Tychan Pte Ltd
Class:
INDUSTRY
Study ID:
ZKT-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tychan Pte Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
Name
Class
National University Hospital Singapore
OTHER
Duke-NUS Graduate Medical School
OTHER
Singapore Clinical Research Institute
OTHER
National University of Singapore
OTHER